- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Transgene SA (0OCQ)
Assess today's live Transgene (TRNG) share price, performance and insights using our live Paris: TRNG stock exchange data.
Analyse the historical data and Transgene share price performance charts on this page. Our technical summary section provides analysis on Transgene share price buy/sell indicators using real-time data (or discuss the Transgene (TRNG) stock price today with other investors in the Transgene EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA TRNG share price (ISIN: FR0005175080) to enhance your trading decisions with our free investment tools and resources.
What Is the Transgene Share Price Today?
The Transgene share price today is 0.618.
What Is the Stock Symbol for Transgene
The stock symbol (or 'ticker') for Transgene is "TRNG."
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris stock exchange.
Is Transgene a Good Stock to Buy?
Determining whether Transgene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Transgene share price performance charts on this page. Our technical summary section provides analysis on Transgene share price buy/sell indicators using real-time data (or discuss the Transgene (TRNG) stock price today with other investors in the Transgene EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA TRNG share price (ISIN: FR0005175080) to enhance your trading decisions with our free investment tools and resources.
What Is the Transgene Share Price Today?
The Transgene share price today is 0.618.
What Is the Stock Symbol for Transgene
The stock symbol (or 'ticker') for Transgene is "TRNG."
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris stock exchange.
Is Transgene a Good Stock to Buy?
Determining whether Transgene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
0.618
-0.028(-4.33%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.618
0.618
52 wk Range
0.608
1.320
0OCQ Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 4 days
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6180.618
52 wk Range
0.6081.320
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
0OCQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
No news in this category
Looks like there are no results in this news category
Transgene Company Profile
Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase I clinical trial for the treatment of ovarian cancer, and head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of HPV-positive cancers; TG6002, an oncolytic virus that is in Phase I/IIa clinical trial for the treatment of gastrointestinal and colorectal cancers; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors. The company also develops TG1050, a therapeutic vaccine for the treatment of hepatitis B; TG6050 for the treatment of non-small cell lung cancer, and Pexa-Vec, an oncolytic virus for the treatment of solid tumors. It has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Merck & Co, Sanofi, BioInvent, and Randox. Transgene SA was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS.
Compare 0OCQ to Peers and Sector
Metrics to compare | 0OCQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0OCQPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | −1.9x | −0.5x | |
PEG Ratio | 0.08 | −0.03 | 0.00 | |
Price/Book | 5.3x | 1.4x | 2.6x | |
Price / LTM Sales | 12.7x | 7.7x | 2.9x | |
Upside (Analyst Target) | - | 229.5% | 66.3% | |
Fair Value Upside | Unlock | 5.9% | 10.2% | Unlock |
Earnings
Latest Release
Mar 27, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Transgene (0OCQ) Stock Price Today?
The Transgene stock price today is 0.618
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the London stock exchange.
What Is the Stock Symbol for Transgene?
The stock symbol for Transgene is "0OCQ."
What Is the Transgene Market Cap?
As of today, Transgene market cap is 80.48M.
What is Transgene Earnings Per Share?
The Transgene EPS is -0.29.
What Is the Next Transgene Earnings Date?
Transgene will release its next earnings report on 23 Apr 2025.
From a Technical Analysis Perspective, Is 0OCQ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.